Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$298K Hold
1,140
– – 0.13% 66
2026
Q2
$287K Buy
+1,140
New +$245K 0.13% 65
2025
Q4
$260K Buy
+1,140
New +$260K 0.17% 62

Other funds holding ABBV

DUNHAM TRUST Co's ABBV Position: Q3 2026 in Review

DUNHAM TRUST Co held its AbbVie (ABBV) position steady in Q3 2026 at 1,140 shares worth $298K. The position accounts for 0.13% of the portfolio, ranked #66.

DUNHAM TRUST Co first reported a position in ABBV in Q4 2025 and has held it in 3 quarters since. 4,228 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • DUNHAM TRUST Co held 1,140 shares of AbbVie worth $298K as of Q3 2026.
  • DUNHAM TRUST Co left its AbbVie share count unchanged in Q3 2026.
  • AbbVie made up 0.13% of DUNHAM TRUST Co's portfolio in Q3 2026, its #66 holding.
  • DUNHAM TRUST Co first reported a position in AbbVie in Q4 2025 and has held it in 3 quarters since.
  • 4,228 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on DUNHAM TRUST Co's 13F filing for Q3 2026, filed 16 Nov 2026.